Public and private healthcare providers are under increasing pressure with the demand for better quality drugs and cheaper healthcare on the rise. However, rising costs and time scales for bringing new drugs to market suggest that challenging times are ahead for many pharmaceutical companies. Current trends in US healthcare indicate that almost half of the hospitals across the country have seen a >20% drop in income. With an additional drop in financial donations, many hospital staff budgets are being cut,…